GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
dc.rights.license | open | en_US |
hal.structure.identifier | Neurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB] | |
dc.contributor.author | QUARTA, Carmelo | |
dc.contributor.author | STEMMER, Kerstin | |
dc.contributor.author | NOVIKOFF, Aaron | |
dc.contributor.author | YANG, Bin | |
dc.contributor.author | KLINGELHUBER, Felix | |
dc.contributor.author | HARGER, Alex | |
dc.contributor.author | BAKHTI, Mostafa | |
dc.contributor.author | BASTIDAS-PONCE, Aimee | |
dc.contributor.author | BAUGE, Eric | |
dc.contributor.author | CAMPBELL, Jonathan E. | |
dc.contributor.author | CAPOZZI, Megan | |
dc.contributor.author | CLEMMENSEN, Christoffer | |
dc.contributor.author | COLLDEN, Gustav | |
dc.contributor.author | COTA, Perla | |
dc.contributor.author | DOUROS, Jon | |
dc.contributor.author | DRUCKER, Daniel J. | |
dc.contributor.author | DUBOIS, Barent | |
dc.contributor.author | FEUCHTINGER, Annette | |
dc.contributor.author | GARCIA-CACERES, Cristina | |
dc.contributor.author | GRANDL, Gerald | |
dc.contributor.author | HENNUYER, Nathalie | |
dc.contributor.author | HERZIG, Stephan | |
dc.contributor.author | HOFMANN, Susanna M. | |
dc.contributor.author | KNERR, Patrick J. | |
dc.contributor.author | KULAJ, Konxhe | |
dc.contributor.author | LALLOYER, Fanny | |
dc.contributor.author | LICKERT, Heiko | |
dc.contributor.author | LISKIEWICZ, Arek | |
dc.contributor.author | LISKIEWICZ, Daniela | |
dc.contributor.author | MAITY, Gandhari | |
dc.contributor.author | PEREZ-TILVE, Diego | |
dc.contributor.author | PRAKASH, Sneha | |
dc.contributor.author | SANCHEZ-GARRIDO, Miguel A. | |
dc.contributor.author | ZHANG, Qian | |
dc.contributor.author | STAELS, Bart | |
dc.contributor.author | KRAHMER, Nathalie | |
dc.contributor.author | DIMARCHI, Richard D. | |
dc.contributor.author | TSCHOP, Matthias H. | |
dc.contributor.author | FINAN, Brian | |
dc.contributor.author | MULLER, Timo D. | |
dc.date.accessioned | 2023-01-31T13:58:05Z | |
dc.date.available | 2023-01-31T13:58:05Z | |
dc.date.issued | 2022-08-04 | |
dc.identifier.issn | 2522-5812 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/171831 | |
dc.description.abstractEn | Dual agonists activating the peroxisome proliferator-activated receptors alpha and gamma (PPARɑ/ɣ) have beneficial effects on glucose and lipid metabolism in patients with type 2 diabetes, but their development was discontinued due to potential adverse effects. Here we report the design and preclinical evaluation of a molecule that covalently links the PPARɑ/ɣ dual-agonist tesaglitazar to a GLP-1 receptor agonist (GLP-1RA) to allow for GLP-1R-dependent cellular delivery of tesaglitazar. GLP-1RA/tesaglitazar does not differ from the pharmacokinetically matched GLP-1RA in GLP-1R signalling, but shows GLP-1R-dependent PPARɣ-retinoic acid receptor heterodimerization and enhanced improvements of body weight, food intake and glucose metabolism relative to the GLP-1RA or tesaglitazar alone in obese male mice. The conjugate fails to affect body weight and glucose metabolism in GLP-1R knockout mice and shows preserved effects in obese mice at subthreshold doses for the GLP-1RA and tesaglitazar. Liquid chromatography–mass spectrometry-based proteomics identified PPAR regulated proteins in the hypothalamus that are acutely upregulated by GLP-1RA/tesaglitazar. Our data show that GLP-1RA/tesaglitazar improves glucose control with superior efficacy to the GLP-1RA or tesaglitazar alone and suggest that this conjugate might hold therapeutic value to acutely treat hyperglycaemia and insulin resistance. © 2022, The Author(s). | |
dc.description.sponsorship | Rôle de Tbx3 dans la détermination de l'identité fonctionnelle des neurones POMC dans l'obésité | en_US |
dc.description.sponsorship | EGID Diabetes Pole | en_US |
dc.language.iso | EN | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject.en | Alkanesulfonic Acid | |
dc.subject.en | Glucagon Like Peptide 1 | |
dc.subject.en | Glucagon Like Peptide 1 Receptor | |
dc.subject.en | Glucose | |
dc.subject.en | Peroxisome Proliferator Activated Receptor Alpha | |
dc.subject.en | Phenylpropionic Acid Derivative | |
dc.subject.en | Tesaglitazar | |
dc.subject.en | Body Weight | |
dc.subject.en | Male | |
dc.subject.en | Metabolism | |
dc.subject.en | Mouse | |
dc.subject.en | Non Insulin Dependent Diabetes Mellitus | |
dc.subject.en | Obesity | |
dc.subject.en | Alkanesulfonates | |
dc.subject.en | Diabetes Mellitus | |
dc.subject.en | Type 2 | |
dc.subject.en | Mice | |
dc.subject.en | Phenylpropionates | |
dc.subject.en | Ppar Alpha | |
dc.title.en | GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice | |
dc.title.alternative | Nat Metab | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1038/s42255-022-00617-6 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] | en_US |
dc.identifier.pubmed | 35995995 | en_US |
bordeaux.journal | Nature Metabolism | en_US |
bordeaux.page | 1071-1083 | en_US |
bordeaux.volume | 4 | en_US |
bordeaux.hal.laboratories | Neurocentre Magendie - U1215 | en_US |
bordeaux.issue | 8 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | INSERM | en_US |
bordeaux.team | Physiopathologie de l'équilibre énergétique et obésité | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.identifier.funderID | Novo Nordisk | en_US |
bordeaux.identifier.funderID | American Friends of the Alexander von Humboldt Foundation | en_US |
bordeaux.identifier.funderID | European Research Council | en_US |
bordeaux.identifier.funderID | Société Française d’Endocrinologie | en_US |
bordeaux.identifier.funderID | Société Française de Nutrition | en_US |
bordeaux.identifier.funderID | Société Francophone du Diabète | en_US |
bordeaux.identifier.funderID | European Genomic Institute for Diabetes | en_US |
hal.identifier | hal-03965703 | |
hal.version | 1 | |
hal.date.transferred | 2023-01-31T13:59:12Z | |
hal.export | true | |
dc.rights.cc | CC BY | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Nature%20Metabolism&rft.date=2022-08-04&rft.volume=4&rft.issue=8&rft.spage=1071-1083&rft.epage=1071-1083&rft.eissn=2522-5812&rft.issn=2522-5812&rft.au=QUARTA,%20Carmelo&STEMMER,%20Kerstin&NOVIKOFF,%20Aaron&YANG,%20Bin&KLINGELHUBER,%20Felix&rft.genre=article |